JIGAR METASTAZLARINI DAVOLASHDA KT NAZORATI OSTIDA AMALGA OSHIRILADIGAN RADIOCHASTOTALI ABLYATSIYA (RCHA) MUOLAJASINING KLINIK SAMARADORLIGI VA XAVFSIZLIGI O‘ZARO MUVOFIQLIGI
DOI:
https://doi.org/10.5281/zenodo.18899952Keywords:
Jigar metastazlari, radiochastotali ablyatsiya, KT nazorati, minimal invaziv davolash, onkologiya, termik ablyatsiya, jigar o‘smalari.Abstract
Jigar metastazlari onkologik kasalliklarning eng ko‘p uchraydigan asoratlaridan biri hisoblanadi va u ko‘pincha yo‘g‘on ichak, oshqozon osti bezi, ko‘krak bezi va boshqa o‘smalarning metastatik tarqalishi natijasida rivojlanadi. Zamonaviy onkologiyada minimal invaziv davolash usullarining ahamiyati ortib bormoqda. Radiochastotali ablyatsiya (RCHA) jigar o‘smalarini davolashda keng qo‘llaniladigan termik destruksiya usullaridan biri bo‘lib, u yuqori chastotali elektr energiyasi yordamida o‘smali to‘qimani koagulyatsion nekrozga uchratishga asoslangan. KT nazorati ostida bajariladigan RCHA o‘smaga elektrodni aniq joylashtirish va ablyatsiya zonasini nazorat qilish imkonini beradi. Tadqiqotlar natijalariga ko‘ra, kichik o‘lchamli metastatik o‘smalarda RCHA yordamida lokal nazorat darajasi 80–90% ga yetishi mumkin. Shu bilan birga, minimal invazivlik, qisqa reabilitatsiya davri va kam asoratlar RCHA usulining klinik amaliyotdagi ahamiyatini oshirmoqda. Ushbu tezisda KT nazorati ostida bajariladigan radiochastotali ablyatsiyaning klinik samaradorligi, xavfsizligi va jigar metastazlarini davolashdagi o‘rni tahlil qilinadi.
References
Adam R. Liver metastases from colorectal cancer: management strategies. Ann Surg Oncol, 2012, p. 1421–1428.
Van Cutsem E. Management of colorectal liver metastases. Lancet Oncology, 2016, p. 873–884.
Goldberg S. Radiofrequency tissue ablation. J Vasc Interv Radiol, 1998, p.101–111.
Wada Y. Efficacy and safety of CT-guided radiofrequency ablation. J Gastroenterology and Hepatology, 2024, p.1–9.
Bowles B. Safety and efficacy of radiofrequency thermal ablation. JAMA Surgery, 2001, p. 819–824.
Lu D. Radiofrequency ablation of hepatic tumors. Radiology, 2005, p.954–960.
Hori T. Risk factors for recurrence after RFA. Journal of Gastroenterology, 2003, p.977–981.
De Baere T. Radiofrequency ablation of hepatic metastases. AJR American Journal of Roentgenology, 2000, p.1619–1625.
Schullian P. Stereotactic radiofrequency ablation for large liver tumors. Scientific Reports, 2020, p.1–8.
Mateva G. PET/CT evaluation after RFA of liver lesions. Molecular Imaging and Radionuclide Therapy, 2021, p.1–7.
Jung J. Safety of radiofrequency ablation for hepatic metastases. Journal of Vascular and Interventional Radiology, 2015, p.245–252.
Pan K. Efficacy of radiofrequency ablation in liver tumors. Oncology Research, 2024, p.115–121.
